CN Patent

CN101087605B — 治疗或预防纤维变性疾病的药物

Assigned to Boehringer Ingelheim International GmbH · Expires 2011-09-14 · 15y expired

What this patent protects

本发明涉及6-位取代的通式(I)的吲哚满酮及其异构体和盐，特别是其药学上可接受的盐，作为预防或治疗特定的纤维变性疾病的药物的用途，式中R 1 ～R 5 和X如权利要求1中所定义的。

USPTO Abstract

本发明涉及6-位取代的通式(I)的吲哚满酮及其异构体和盐，特别是其药学上可接受的盐，作为预防或治疗特定的纤维变性疾病的药物的用途，式中R 1 ～R 5 和X如权利要求1中所定义的。

Drugs covered by this patent

Patent Metadata

Patent number
CN101087605B
Jurisdiction
CN
Classification
—
Expires
2011-09-14
Drug substance claim
No
Drug product claim
No
Assignee
Boehringer Ingelheim International GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.